505 related articles for article (PubMed ID: 22693444)
21. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.
King DF; Siddiqui AA; Buffa V; Fischetti L; Gao Y; Stieh D; McKay PF; Rogers P; Ochsenbauer C; Kappes JC; Arts EJ; Shattock RJ
J Virol; 2013 Jan; 87(2):890-9. PubMed ID: 23135721
[TBL] [Abstract][Full Text] [Related]
22. Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.
Ping LH; Joseph SB; Anderson JA; Abrahams MR; Salazar-Gonzalez JF; Kincer LP; Treurnicht FK; Arney L; Ojeda S; Zhang M; Keys J; Potter EL; Chu H; Moore P; Salazar MG; Iyer S; Jabara C; Kirchherr J; Mapanje C; Ngandu N; Seoighe C; Hoffman I; Gao F; Tang Y; Labranche C; Lee B; Saville A; Vermeulen M; Fiscus S; Morris L; Karim SA; Haynes BF; Shaw GM; Korber BT; Hahn BH; Cohen MS; Montefiori D; Williamson C; Swanstrom R;
J Virol; 2013 Jul; 87(13):7218-33. PubMed ID: 23616655
[TBL] [Abstract][Full Text] [Related]
23. The Role of Integrin α
Kasarpalkar N; Deb B; Kumar P; Bhor VM
OMICS; 2020 Jul; 24(7):437-450. PubMed ID: 32522079
[TBL] [Abstract][Full Text] [Related]
24. The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.
Nawaz F; Cicala C; Van Ryk D; Block KE; Jelicic K; McNally JP; Ogundare O; Pascuccio M; Patel N; Wei D; Fauci AS; Arthos J
PLoS Pathog; 2011 Feb; 7(2):e1001301. PubMed ID: 21383973
[TBL] [Abstract][Full Text] [Related]
25. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
Foda M; Harada S; Maeda Y
Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages.
Han M; Cantaloube-Ferrieu V; Xie M; Armani-Tourret M; Woottum M; Pagès JC; Colin P; Lagane B; Benichou S
PLoS Pathog; 2022 May; 18(5):e1010335. PubMed ID: 35622876
[TBL] [Abstract][Full Text] [Related]
27. Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.
Bouvin-Pley M; Beretta M; Moreau A; Roch E; Essat A; Goujard C; Chaix ML; Moiré N; Martin L; Meyer L; Barin F; Braibant M
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567994
[TBL] [Abstract][Full Text] [Related]
28. South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication.
Richardson SI; Gray ES; Mkhize NN; Sheward DJ; Lambson BE; Wibmer CK; Masson L; Werner L; Garrett N; Passmore JA; Karim QA; Karim SS; Williamson C; Moore PL; Morris L
Retrovirology; 2015 Jun; 12():54. PubMed ID: 26105197
[TBL] [Abstract][Full Text] [Related]
29. Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Hunter E; Derdeyn CA
PLoS Pathog; 2016 Nov; 12(11):e1005989. PubMed ID: 27851829
[TBL] [Abstract][Full Text] [Related]
30. Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.
Liao HX; Tsao CY; Alam SM; Muldoon M; Vandergrift N; Ma BJ; Lu X; Sutherland LL; Scearce RM; Bowman C; Parks R; Chen H; Blinn JH; Lapedes A; Watson S; Xia SM; Foulger A; Hahn BH; Shaw GM; Swanstrom R; Montefiori DC; Gao F; Haynes BF; Korber B
J Virol; 2013 Apr; 87(8):4185-201. PubMed ID: 23365441
[TBL] [Abstract][Full Text] [Related]
31. Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
Espy N; Pacheco B; Sodroski J
Virology; 2017 Aug; 508():90-107. PubMed ID: 28521215
[TBL] [Abstract][Full Text] [Related]
32. Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip.
Koma T; Yokoyama M; Kotani O; Doi N; Nakanishi N; Okubo H; Adachi S; Adachi A; Sato H; Nomaguchi M
J Virol; 2021 Jun; 95(13):e0217720. PubMed ID: 33883222
[TBL] [Abstract][Full Text] [Related]
33. Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α
Plotnik D; Guo W; Cleveland B; von Haller P; Eng JK; Guttman M; Lee KK; Arthos J; Hu SL
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814519
[TBL] [Abstract][Full Text] [Related]
34. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.
Puffer BA; Pöhlmann S; Edinger AL; Carlin D; Sanchez MD; Reitter J; Watry DD; Fox HS; Desrosiers RC; Doms RW
J Virol; 2002 Mar; 76(6):2595-605. PubMed ID: 11861825
[TBL] [Abstract][Full Text] [Related]
35. Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.
Ringe R; Thakar M; Bhattacharya J
Retrovirology; 2010 Sep; 7():76. PubMed ID: 20860805
[TBL] [Abstract][Full Text] [Related]
36. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.
Ochsenbauer C; Edmonds TG; Ding H; Keele BF; Decker J; Salazar MG; Salazar-Gonzalez JF; Shattock R; Haynes BF; Shaw GM; Hahn BH; Kappes JC
J Virol; 2012 Mar; 86(5):2715-28. PubMed ID: 22190722
[TBL] [Abstract][Full Text] [Related]
37. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DF; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR
J Virol; 2009 Jun; 83(11):5430-41. PubMed ID: 19321618
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal analysis of subtype C envelope tropism for memory CD4
Gartner MJ; Gorry PR; Tumpach C; Zhou J; Dantanarayana A; Chang JJ; Angelovich TA; Ellenberg P; Laumaea AE; Nonyane M; Moore PL; Lewin SR; Churchill MJ; Flynn JK; Roche M
Retrovirology; 2020 Aug; 17(1):24. PubMed ID: 32762760
[TBL] [Abstract][Full Text] [Related]
39. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
[TBL] [Abstract][Full Text] [Related]
40. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
